Table of contents
Volume 99, Issue 7
Published online 30 September 2008 (989-1196)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Minireviews
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer FREE
E D Michelakis, L Webster and J R Mackey
Br J Cancer 99: 989-994; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604554
Can weight loss prevent cancer? FREE
K Y Wolin and G A Colditz
Br J Cancer 99: 995-999; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604623
Clinical Studies
Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer FREE
C C Kirwan, G McDowell, C N McCollum, S Kumar and G J Byrne
Br J Cancer 99: 1000-1006; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604620
Mammographic screening for young women with a family history of breast cancer: knowledge and views of those at risk FREE
S Tyndel, A Clements, C Bankhead, B J Henderson, K Brain, E Watson and J Austoker for the PIMMS Study Management Group
Br J Cancer 99: 1007-1012; doi:10.1038/sj.bjc.6604672
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer FREE
AM Al Murri, M Hilmy, J Bell, C Wilson, A-M McNicol, A Lannigan, J C Doughty and D C McMillan
Br J Cancer 99: 1013-1019; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604667
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial FREE
S Lorenzen, B Brücher, F Zimmermann, H Geinitz, J Riera, T Schuster, N Roethling, H Höfler, K Ott, C Peschel, J R Siewert, M Molls and F Lordick
Br J Cancer 99: 1020-1026; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604659
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group FREE
B De Bernardi, V Mosseri, H Rubie, V Castel, A Foot, R Ladenstein, G Laureys, M Beck-Popovic, A F de Lacerda, A D J Pearson, J De Kraker, P F Ambros, Y de Rycke, M Conte, P Bruzzi and J Michon
Br J Cancer 99: 1027-1033; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604640
Silent venous thromboembolism before treatment in endometrial cancer and the risk factors FREE
T Satoh, K Matsumoto, K Uno, M Sakurai, S Okada, M Onuki, T Minaguchi, Y O Tanaka, S Homma, A Oki and H Yoshikawa
Br J Cancer 99: 1034-1039; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604658
Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study FREE
C Metcalfe, S Evans, F Ibrahim, B Patel, K Anson, F Chinegwundoh, C Corbishley, D Gillatt, R Kirby, G Muir, V Nargund, R Popert, R Persad and Y Ben-Shlomo on behalf of the PROCESS study group
Br J Cancer 99: 1040-1045; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604670
The impact of old age on cancer-specific and non-cancer-related survival following elective potentially curative surgery for Dukes A/B colorectal cancer FREE
D C McMillan, D J Hole and C S McArdle
Br J Cancer 99: 1046-1049; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604669
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy FREE
L Paré, E Marcuello, A Altés, E del Río, L Sedano, J Salazar, A Cortés, A Barnadas and M Baiget
Br J Cancer 99: 1050-1055; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604671
Translational Therapeutics
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate FREE
M J Scandlyn, E C Stuart, T J Somers-Edgar, A R Menzies and R J Rosengren
Br J Cancer 99: 1056-1063; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604634
BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation FREE
R Hennig, T Osman, I Esposito, N Giese, S M Rao, X-Z Ding, W-G Tong, M W Büchler, T Yokomizo, H Friess and T E Adrian
Br J Cancer 99: 1064-1073; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604655
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer FREE
Q Chang, C Jorgensen, T Pawson and D W Hedley
Br J Cancer 99: 1074-1082; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604676
Molecular Diagnostics
The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death FREE
L F Grochola, T Greither, H Taubert, P Möller, U Knippschild, A Udelnow, D Henne-Bruns and P Würl
Br J Cancer 99: 1083-1088; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604653
Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients FREE
M Aubele, A K Walch, N Ludyga, H Braselmann, M J Atkinson, B Luber, G Auer, S Tapio, T Cooke and J M S Bartlett
Br J Cancer 99: 1089-1095; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604660
Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer FREE
Y-F Huang, M-R Shen, K-F Hsu, Y-M Cheng and C-Y Chou
Br J Cancer 99: 1096-1102; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604661
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel FREE
K Oikonomopoulou, L Li, Y Zheng, I Simon, R L Wolfert, D Valik, M Nekulova, M Simickova, T Frgala and E P Diamandis
Br J Cancer 99: 1103-1113; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604630
Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion FREE
L A Lambert, A R Whyteside, A J Turner and B A Usmani
Br J Cancer 99: 1114-1120; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604631
Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma FREE
D Wangsa, M Ryott, E Åvall-Lundqvist, F Petersson, G Elmberger, J Luo, T Ried, G Auer and E Munck-Wikland
Br J Cancer 99: 1121-1128; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604633
Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma FREE
U Tabori, V Wong, J Ma, M Shago, N Alon, J Rutka, E Bouffet, U Bartels, D Malkin and C Hawkins
Br J Cancer 99: 1129-1135; advance online publication, September 16, 2008; doi:10.1038/sj.bjc.6604652
Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma FREE
V Rand, E Prebble, L Ridley, M Howard, W Wei, M-A Brundler, B E Fee, G J Riggins, B Coyle and R G Grundy on behalf of the Children's Cancer and Leukaemia Group Biological Studies Committee
Br J Cancer 99: 1136-1143; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604651
p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours FREE
M Dimitriadi, G Poulogiannis, L Liu, L M Bäcklund, D M Pearson, K Ichimura and V P Collins
Br J Cancer 99: 1144-1152; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604643
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker? FREE
L Karayan-Tapon, M Wager, J Guilhot, P Levillain, C Marquant, J Clarhaut, V Potiron and J Roche
Br J Cancer 99: 1153-1160; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604641
Epidemiology
Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations FREE
R Troisi, R N Hoover, R Thadhani, C-C Hsieh, P Sluss, R Ballard-Barbash and N Potischman
Br J Cancer 99: 1161-1164; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604639
Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study FREE
T Bjørge, A Engeland, S Tretli and I Heuch
Br J Cancer 99: 1165-1169; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604646
Dietary glycaemic index, glycaemic load and breast cancer risk: a systematic review and meta-analysis FREE
H G Mulholland, L J Murray, C R Cardwell and M M Cantwell
Br J Cancer 99: 1170-1175; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604618
Complexities in the estimation of overdiagnosis in breast cancer screening FREE
S W Duffy, E Lynge, H Jonsson, S Ayyaz and A H Olsen
Br J Cancer 99: 1176-1178; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604638
Green tea consumption and lung cancer risk: the Ohsaki study FREE
Q Li, M Kakizaki, S Kuriyama, T Sone, H Yan, N Nakaya, K Mastuda-Ohmori and I Tsuji
Br J Cancer 99: 1179-1184; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604645
Determinants of the number of mammography units in 31 countries with significant mammography screening FREE
P Autier and D A Ouakrim
Br J Cancer 99: 1185-1190; advance online publication, September 9, 2008; doi:10.1038/sj.bjc.6604657
Letters to the Editor
Reply: Childhood leukaemia and population movements in France, 1990–2003 FREE
S Bellec and J Clavel
Br J Cancer 99: 1191; doi:10.1038/sj.bjc.6604552
Reply: Population change, population mixing and incidence of childhood acute lymphoblastic leukaemia in England and Wales FREE
C A Stiller, M E Kroll, P J Boyle and Z Feng
Br J Cancer 99: 1192-1193; doi:10.1038/sj.bjc.6604553
'Population mixing, socio-economic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales – analysis by census ward' and 'Childhood leukaemia and population movements in France, 1990–2003' FREE
R Wakeford
Br J Cancer 99: 1194; doi:10.1038/sj.bjc.6604551
Molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation FREE
J A Ajani
Br J Cancer 99: 1195; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604627
Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation FREE
R Yoshikawa, M Sasako and Y Fujiwara
Br J Cancer 99: 1196; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604647
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
